Soraya Seedat Selected Research

Soraya Seedat Research Topics

Disease

35	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 02/2022 - 06/2000
16	Wounds and Injuries (Trauma) 01/2022 - 01/2005
9	Mental Disorders (Mental Disorder) 01/2022 - 01/2008
7	Anxiety Disorders (Anxiety Disorder) 01/2022 - 10/2003
6	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2013 - 01/2002
5	Neurocognitive Disorders (Clerambault Syndrome) 06/2022 - 06/2012
4	Schizophrenia (Dementia Praecox) 01/2022 - 01/2016
4	Inflammation (Inflammations) 01/2022 - 01/2017
4	Alcoholism (Alcohol Abuse) 01/2018 - 05/2011
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 08/2012
3	Mood Disorders (Mood Disorder) 01/2022 - 01/2004
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2020
3	HIV Infections (HIV Infection) 01/2021 - 01/2019
3	Disease Progression 01/2021 - 05/2007
3	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2018
3	Substance-Related Disorders (Drug Abuse) 01/2017 - 08/2012
3	Social Phobia 07/2006 - 02/2004
2	COVID-19 06/2022 - 10/2021
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2022
2	Hypertension (High Blood Pressure) 01/2022 - 12/2012
2	Cognitive Dysfunction 01/2021 - 01/2019
2	Fetal Alcohol Spectrum Disorders 01/2021 - 01/2021
2	Neuroinflammatory Diseases 01/2020 - 01/2018
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 04/2017
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2019 - 01/2017
2	Trichotillomania 09/2006 - 06/2002
2	Syndrome (Syndromes) 01/2005 - 10/2003
2	Panic Disorder (Panic Attack) 02/2004 - 09/2003
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Depressive Disorder (Melancholia) 01/2022
1	Infections 01/2022
1	Insulin Resistance 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Abdominal Obesity 01/2022
1	Movement Disorders (Movement Disorder) 10/2020
1	Dystonic Disorders (Writer's Cramp) 10/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Anhedonia 01/2020

Drug/Important Bio-Agent (IBA)

12	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2018 - 06/2000
8	Pharmaceutical PreparationsIBA 01/2018 - 09/2003
6	Citalopram FDA LinkGeneric 10/2004 - 06/2000
5	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 06/2007
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2013
4	Biological ProductsIBA 10/2021 - 01/2008
4	Dopamine (Intropin)FDA LinkGeneric 10/2019 - 01/2013
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2016 - 01/2013
4	Serotonin (5 Hydroxytryptamine)IBA 05/2004 - 06/2000
3	Hormones (Hormone)IBA 01/2022 - 01/2005
3	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2013
3	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 11/2006
3	Escitalopram FDA Link 03/2018 - 06/2008
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2012
3	Risperidone (Risperdal Consta)FDA LinkGeneric 08/2005 - 08/2005
2	MicronutrientsIBA 01/2022 - 12/2012
2	CytokinesIBA 01/2021 - 01/2021
2	Cycloserine (Seromycin)FDA Link 01/2020 - 01/2017
2	GlucocorticoidsIBA 01/2020 - 01/2020
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2013 - 07/2006
2	Quetiapine Fumarate (Seroquel)FDA Link 11/2006 - 01/2005
2	Inositol (Myoinositol)IBA 08/2005 - 01/2002
2	Paroxetine (Paxil)FDA LinkGeneric 02/2004 - 10/2003
2	AminesIBA 01/2004 - 06/2002
2	OximesIBA 01/2004 - 06/2002
1	SuspensionsIBA 06/2022
1	Tacrolimus Binding Proteins (FKBP)IBA 01/2022
1	AshwagandhaIBA 01/2022
1	N 30IBA 01/2022
1	Acetylcarnitine (Alcar)IBA 01/2022
1	CurcuminIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Methionine (L-Methionine)FDA Link 01/2022
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	ZincIBA 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	ChemokinesIBA 01/2021
1	telomerase RNA (bTR)IBA 01/2021
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Haloperidol (Haldol)FDA LinkGeneric 10/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Cortisone FDA Link 01/2020
1	CorticosteroneIBA 01/2020

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 02/2022 - 06/2002
6	Therapeutics 06/2022 - 11/2013
5	Aftercare (After-Treatment) 01/2020 - 05/2004
3	Secondary Prevention 03/2018 - 12/2012
2	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 08/2012
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Time-to-Treatment 01/2022